Singapore HSA Updates Good Distribution Practice Guides for Therapeutic Products

In December 2023, HSA updated the following Good Distribution Practice (GDP) guides: – GUIDANCE NOTES ON GOOD DISTRIBUTION PRACTICE    …

read more...

Singapore HSA Publishes List of Acceptable Intake for Nitrosamines

In March 2020, HSA had communicated the regulatory requirement to conduct risk assessments for all therapeutic products containing chemically synthesized …

read more...

Singapore HSA Publishes Cosmetic Products Guidance on Adverse Effects Reporting, Product Defects and Product Recalls

In December 2023, HSA’s Complementary Health Products Branch publishes guidance on “Procedures for Reporting of Adverse Effects, Product Defects and …

read more...

Singapore HSA Announces Upcoming Regulatory Fee Revision for Health Products

Singapore’s Health Sciences Authority (HSA) regulates health products to ensure that they meet the required standards of quality, safety and …

read more...

WHO: Singapore HSA, Korea MFDS, and Switzerland Swissmedic are the first three countries to be listed as WHO-Listed Authorities (WLA)

Korea MFDS, Singapore HSA and Switzerland Swissmedic are the first 3 countries to be listed as WHO-Listed Authorities (WLA). This …

read more...

Minister of Finance of Vietnam Promulgates Circular Prescribing Fees in Medical Device Sector

Circular 59/2023/TT-BTC introduces regulations on fees in medical sector, and the collection, transfer, management and use thereof. Such fees in …

read more...

FDA PH Issues Guidelines on the Publishing of Package Insert and Patient Information Leaflet of Registered Drug Products in the Food and Drug Administration (FDA) Verification Portal System

Guidelines: A. Approved PI and PIL of all registered drug products shall be published by the FDA in the Verification …

read more...

Singapore HSA Implements GMP Evidence for Drug Substance Manufacturers

As part of a continual regulatory enhancement to ensure the quality standard of therapeutic products supplied in Singapore, Singapore’s Health …

read more...

Singapore HSA Revises Medical Device Adverse Events Reporting Guideline

Singapore HSA revised GN-05: Guidance on the Reporting of Adverse Events for Medical Devices with the following update: – Included …

read more...